Dana ChrengAssociate Director- Drug Substance Manufacturing Group at Ionis PharmaceuticalsSpeaker
Agenda Sessions
New Approaches to Expand Horizons in the Production of Peptides and Oligonucleotides
10:00amView SessionUtilization of a TFF skid for solution-phase deprotection and small molecule removal in oligonucleotide manufacturing
9:20amView Session